New Obesity Drug MariTide Helps Patients Lose Up to 20% of Weight, Early Data Shows
The drug, which is named MariTide and delivered in a monthly injection, is some time away from being sold.
Read more at The New York Times
Topics
-
Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
Business - CNBC - 10 hours ago -
Even with access to blockbuster obesity drugs, some people don't lose weight
Health - ABC News - 3 days ago -
Biden proposes Medicare and Medicaid cover weight-loss drugs for obese Americans
Health - ABC News - 11 hours ago -
Weight-loss-drug makers’ stocks get a boost from new Biden coverage proposal, but will it hold up?
Business - MarketWatch - 18 hours ago
More from The New York Times
-
Trump’s Tariffs Would Deal a Big Blow to the Auto Industry
Business - The New York Times - 9 hours ago -
China’s Huawei Takes Aim at Apple With Latest Smartphone
Business - The New York Times - 22 hours ago -
Yes, It ‘Looks Like a Duck,’ but Carriers Like the New Mail Truck
Business - The New York Times - 9 hours ago -
Biden Cuts Intel’s Chip Award by More Than $600 Million
Business - The New York Times - 15 hours ago -
Trump Taps Kevin Hassett to Lead National Economic Council
Business - The New York Times - 5 hours ago